Research output per year
Research output per year
Project Details
Project Description
This project will utilise the information from the determination of the complete genome sequence of Leptospira borgpetersenii serovar Hardjobovis at Monash University. Bioinformations analysis will be used to allow a global approach to idenitfy all putative vaccine antigens. Using the hight throughput protein production unit at Monash University, candidiate proteins will be cloned, expressed and purified and their productive capacity investigated.
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/06 → 31/12/08 |
Funding
- Australian Research Council (ARC): A$510,000.00
- Pfizer (Australia) (trading as Pfizer Australia Pty Limited): A$339,000.00
- Pfizer (Australia) (trading as Pfizer Australia Pty Limited): A$48,033.00
Research output
- 1 Article
-
Recombinant LipL32 stimulates interferon-gamma production in cattle vaccinated with a monovalent Leptospira borgpetersenii serovar Hardjo subtype Hardjobovis vaccine
Deveson, D. S., Lo, M., Bulach, D. M., Quinsey, N. S., Murray, G. L., Allen, A. & Adler, B., 2014, In: Veterinary Microbiology. 169, 3-4, p. 163 - 170 8 p.Research output: Contribution to journal › Article › Research › peer-review
11 Citations (Scopus)